Merck KGaA, Darmstadt, Germany: all 522 studies

Page 3 of 6. Open to participants first (18), then studies with results posted, then the rest; newest registration first within each.

• Saizen® Solution for Injection Adult Growth Hormone Deficiency (GHD) Immunogenicity StudyTerminatedNCT01237340Phase 3Results posted
• A Trial to Compare Oxaliplatin, Folinic Acid (FA) and 5-Fluorouracil (5FU) Combination Chemotherapy (FOLFOX-4) With or Without Cetuximab in the 1st Line Treatment of Metastatic Colorectal Cancer (mCRC) in Chinese Rat Sarcoma Viral Oncogene Homolog (RAS) Wild-type PatientsCompletedNCT01228734Phase 3Results posted
• Phase 2 Extension Trial in Patients With Relapsing-Remitting Multiple Sclerosis (RRMS)TerminatedNCT01226745Phase 2Results posted
• EXpression PRofile Endometrium Samples StudyTerminatedNCT01210144Phase 4Results posted
• Retrospective Cohort Study of Rebif® Use in Pediatric Multiple Sclerosis (MS) Subjects (REPLAY)CompletedNCT01207648Results posted
• Evaluation of Emotional Disorders During Treatment by Interferon Beta in Relapsing-remitting Multiple Sclerosis PatientsCompletedNCT01201343Phase 4Results posted
• A Multicentre Study of the Efficacy and Safety of Supplementary Treatment With Cholecalciferol in Patients With Relapsing Multiple Sclerosis Treated With Subcutaneous Interferon Beta-1a 44 µg 3 Times WeeklyCompletedNCT01198132Phase 2Results posted
• A 12-week, Multicentric Study to Evaluate the Safety and Efficacy of Bisoprolol in Filipino Hypertensive Subjects With DiabetesCompletedNCT01190436Phase 4Results posted
• Predictive Markers in Chinese Growth Hormone Deficiency (GHD) Children Treated With Saizen®CompletedNCT01187550Phase 4Results posted
• SJ-0021 (Gonalef®) Versus Purified Pituitary Gonadotropin (Fertinorm-P®) for Ovulation Induction in Japanese Infertile WomenCompletedNCT01185782Phase 3Results posted
• Analysis of Two Therapeutic With Cetrotide® in Polycystic Ovarian (PCO) Women in Assisted Reproductive Technology (ART)CompletedNCT01185704Phase 3Results posted
• Convenience and Safety of Assisted Reproductive Technology Procedures Using a Gonal-F Filled by Mass (Fbm) Liquid Formulation Applied by Pen for Ovulation Induction and In-vitro FertilizationCompletedNCT01183143Phase 3Results posted
• A Trial to Determine the Safety and Anti-tumor Activity Profile of the Combination of Cetuximab and Concomitant Cisplatin Plus 5-Fluorouracil (5-FU) in Subjects With Recurrent and/or Metastatic Squamous Cell Carcinoma in Head and NeckCompletedNCT01177956Phase 3Results posted
• Colposeptine for the Treatment of Bacterial VaginosisTerminatedNCT01153958Phase 4Results posted
• A Phase IV Study of Rebif ® 44mcg Administered Three Times Per Week by Subcutaneous Injection Compared With no Treatment in the Therapy of Relapsing Multiple Sclerosis After MitoxantroneCompletedNCT01142466Phase 4Results posted
• Minocycline as add-on to Interferon Beta-1a [IFN Beta-1a] (Rebif®) in Relapsing-Remitting Multiple Sclerosis [RRMS]TerminatedNCT01134627Phase 2Results posted
• A Prospective Study to Evaluate the Addition of Subcutaneous Recombinant Human-Luteinizing Hormone With Recombinant Human-Follicle Stimulating Hormone on Follicular Development in Women Undergoing Ovarian Stimulation for Assisted Reproductive TechnologiesCompletedNCT01121991Phase 3Results posted
• Lutropin Alfa in Women at Risk of Poor ResponseCompletedNCT01112358Phase 2Results posted
• Efficacy and Safety Evaluation of Recombinant Human Growth Hormone (r-hGH), Saizen®, on a Population of Children With Hypochondroplasia, Treated at Least 3 Years or Until Near Final Height, When Applicable, in Comparison With a Historic Cohort of Non-treated ChildrenCompletedNCT01111019Phase 2Results posted
• A Randomised, Phase II, Comparative Study With a Parallel Control for Evaluating the Efficacy and Safety of Combined Treatment of Lutropin Alpha and Recombinant Human Luteinizing Hormone in the Middle of the Controlled Ovarian Stimulation Follicular Phase in Women With Reduced Ovarian ReserveCompletedNCT01110707Phase 2Results posted
• Association Between Genetic Polymorphism of Beta-adrenergic Receptor and Effects of Bisoprolol in Korean Heart Failure Patients.CompletedNCT01104558Phase 4Results posted
• Study of Tecemotide (L-BLP25) in Subjects With Slowly Progressive Multiple Myeloma With no Symptoms and Who Have Had no ChemotherapyCompletedNCT01094548Phase 2Results posted
• MEK Inhibitor MSC1936369B Plus FOLFIRI in Second Line K-Ras Mutated Metastatic Colorectal Cancer (mCRC)TerminatedNCT01085331Phase 1/2Results posted
• Rebif Advanced Magnetic Resonance Imaging (MRI) and Immunology Pilot TrialCompletedNCT01085318Phase 4Results posted
• A Study Using Recombinant Human Luteinizing Hormone (r-hLH, Luveris®) in the Treatment of Chinese Women With Hypogonadotropic HypogonadismCompletedNCT01084265Phase 3Results posted
• Response to Kuvan® in Subjects With Phenylketonuria (PKU) in a 4 Weeks Testing PeriodCompletedNCT01082328Phase 4Results posted
• Recombinant Follicle Stimulating Hormone (FSH) (Gonal-f®): Use in Ovulation InductionCompletedNCT01081626Phase 4Results posted
• Study of Therapeutic Options for Subjects Discontinuing Efalizumab and Experiencing Disease RecurrenceCompletedNCT01079988Phase 4Results posted
• An Active-controlled, Clinical Trial to Assess Central Hemodynamic Effects of Bisoprolol in Hypertensive Patients (Central Hemodynamic Assessment Measured in Patient With HypertensION [CHAMPION])CompletedNCT01079962Phase 4Results posted
• A Phase II Study to Assess the Efficacy and Safety of Luveris® (Lutropin Alfa) in Mid Follicular Phase for Controlled Ovarian Stimulation (COS) in Advanced Reproductive AgeTerminatedNCT01079949Phase 2Results posted
• Safety and Efficacy Study of Serostim® Human Immunodeficiency Virus-Associated Adipose Redistribution SyndromeCompletedNCT01077960Phase 3Results posted
• A Clinical Trial to Determine the Effect of Lutropin Alfa on Embryo Quality and Implantation Rate in Advanced Reproductive AgeTerminatedNCT01075815Phase 2Results posted
• A Pilot Trial of Interferon Beta-1a in Alzheimer's DiseaseCompletedNCT01075763Phase 2Results posted
• A Prospective, Open-labeled, Multi-centric Trial in Subjects With Systolic Heart Failure to Evaluate Bisoprolol Treatment for the Effects on Surrogate Markers of Heart Failure in KoreaCompletedNCT01074307Phase 4Results posted
• Study to Evaluate if the Addition of r-hLH (Luveris®) to FSH From Day 8 of Ovarian Stimulation is Able to Decrease Total FSH Dose and to Improve Cycle Outcome in Infertile Women Undergoing ART, Who Required High FSH Dose in a Previous CycleTerminatedNCT01071200Phase 3Results posted
• A Trial to Evaluate the Correlation Between Spontaneous Catch-up Growth, Clinical Response to Saizen (Recombinant Human Growth Hormone, r-hGH) and Gene Expression Profiling in Children Small for Gestational Age (SGA)TerminatedNCT01067352Phase 3Results posted
• Sprifermin (AS902330) in Cartilage Injury Repair (CIR)TerminatedNCT01066871Phase 2Results posted
• Growth Hormone Treatment for the Prevention of Short Stature in Young Girls With Turner Syndrome Before the Age of 4 YearsCompletedNCT01066052Phase 4Results posted
• Phase 4 Study to Assess the Effect of Bisoprolol on Glycemic Level in Type II Diabetic Subjects With Suboptimal Blood Pressure ControlCompletedNCT01066039Phase 4Results posted
• EMD 1201081 in Combination With Cetuximab in Second-Line Cetuximab-Naïve Subjects With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckCompletedNCT01040832Phase 2Results posted
• A Multicenter, Open-label, RebiSmart™ Autoinjector Ease of Use StudyCompletedNCT01036165Phase 3Results posted
• The REbif® vs Glatiramer Acetate in Relapsing Multiple Sclerosis Pharmacogenetics TrialCompletedNCT01034579Phase 4Results posted
• Trial of Gemcitabine With or Without MSC1936369B in Pancreatic CancerCompletedNCT01016483Phase 1/2Results posted
• Cancer Vaccine Study for Stage III, Unresectable, Non-small Cell Lung Cancer (NSCLC) in the Asian PopulationTerminatedNCT01015443Phase 3Results posted
• First-in-Man, Dose-escalation Trial of C-met Kinase Inhibitor MSC2156119J in Subjects With Advanced Solid TumorsCompletedNCT01014936Phase 1Results posted
• Prospective Observational Long-term Safety Registry of Multiple Sclerosis Participants Who Have Participated in Cladribine Clinical TrialsCompletedNCT01013350Results posted
• Cetuximab With Radiotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck in Chinese SubjectsCompletedNCT01012258Phase 3Results posted
• EMD 525797 in Combination With Cetuximab and Irinotecan in K-ras Wild Type Metastatic Colorectal CancerCompletedNCT01008475Phase 1/2Results posted
• Trial of MSC1936369B in Subjects With Solid TumorsCompletedNCT00982865Phase 1Results posted
• Raptiva in Palm and Sole PsoriasisTerminatedNCT00972543Phase 4Results posted
• Study of Cetuximab in Combination With Chemotherapy in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)CompletedNCT00971932Phase 2Results posted
• Study of Tecemotide (L-BLP25) in Participants With Stage III Unresectable Non-small Cell Lung Cancer (NSCLC) Following Primary ChemoradiotherapyCompletedNCT00960115Phase 1/2Results posted
• A Study to Determine the Safety, Tolerability, Pharmacokinetics and Dynamic Effects of Different Doses of the Study Drug EMD 525797 in Prostate CancerCompletedNCT00958477Phase 1Results posted
• The Multicenter, Open-label, Single-use Autoinjector Convenience StudyCompletedNCT00958009Phase 3Results posted
• Trial of Pimasertib in Hematological MalignanciesTerminatedNCT00957580Phase 2Results posted
• Drug-Drug Interaction of Cladribine and Pantoprazole in Multiple Sclerosis SubjectsCompletedNCT00938366Phase 1Results posted
• Growth Hormone in Neuroendocrine Dysfunction With Severe Fibromyalgia SyndromeCompletedNCT00933686Phase 3Results posted
• STRIDE - STimulating Immune Response In aDvanced brEast CancerTerminatedNCT00925548Phase 3Results posted
• Study of Cetuximab With Concomitant-boost Radiotherapy in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)CompletedNCT00865098Phase 2Results posted
• Atacicept in Multiple Sclerosis Extension Study, Phase IITerminatedNCT00853762Phase 2Results posted
• EMD 525797 in Colorectal and Ovarian Cancer Patients With Liver MetastasesCompletedNCT00848510Phase 1Results posted
• Cilengitide and Cetuximab in Combination With Platinum-based Chemotherapy as First-line Treatment for Subjects With Advanced Non Small Cell Lung Cancer (NSCLC)CompletedNCT00842712Phase 2Results posted
• CONSORT Randomized Controlled Trial in Assisted Reproductive TechnologyCompletedNCT00829244Phase 4Results posted
• Trial With Cetuximab in Maintenance Therapy After Platinum Based Chemotherapy in First Line Treatment of Non-small Cell Lung Cancer (NSCLC)CompletedNCT00820755Phase 3Results posted
• Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Unmethylated Gene Promoter StatusCompletedNCT00813943Phase 2Results posted
• Long-term Follow-Up of Patients Who Participated in Study 27025 (REFLEX)CompletedNCT00813709Phase 3Results posted
• Study Evaluating the Safety and Efficacy of FOLFIRI Plus Cetuximab or FOLFOX Plus Cetuximab as First-line Therapy in Subjects With KRAS Wild-type Metastatic Colorectal Cancer (APEC-Study)CompletedNCT00778830Phase 1/2Results posted
• TRUST Study: Raptiva ® in Hand & Foot PsoriasisTerminatedNCT00739882Phase 4Results posted
• 12-week Study to Evaluate RebiSmart™ Suitability for Self Injection in Relapsing Multiple Sclerosis.CompletedNCT00735007Phase 3Results posted
• Oral Cladribine in Early Multiple Sclerosis (MS)CompletedNCT00725985Phase 3Results posted
• Cilengitide in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)CompletedNCT00705016Phase 1/2Results posted
• Oocyte Cryopreservation Registry (HOPE Registry)CompletedNCT00699400Results posted
• ChangE From Any Systemic psoriasiS therapY to RaptivaTerminatedNCT00697593Phase 4Results posted
• Easypod United States User TrialCompletedNCT00689260Phase 4Results posted
• Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Methylated Gene Promoter StatusCompletedNCT00689221Phase 3Results posted
• Erbitux in Combination With Xeloda and Cisplatin in Advanced Esophago-gastric CancerCompletedNCT00678535Phase 3Results posted
• Atacicept in Combination With Rituximab in Subjects With Rheumatoid Arthritis (August III)CompletedNCT00664521Phase 2Results posted
• A Phase 2 Study of Atacicept in Subjects With Relapsing Multiple Sclerosis (ATAMS)TerminatedNCT00642902Phase 2Results posted
• CLARITY Extension StudyCompletedNCT00641537Phase 3Results posted
• Atacicept in Subjects With Optic NeuritisTerminatedNCT00624468Phase 2Results posted
• Atacicept Phase 2/3 in Generalized Systemic Lupus Erythematosus (APRIL-SLE)CompletedNCT00624338Phase 2/3Results posted
• Transition to Rebif New FormulationCompletedNCT00619307Phase 3Results posted
• Atacicept in Anti-Tumor Necrosis Factor Alpha-naïve Subjects With Rheumatoid Arthritis (AUGUST II)CompletedNCT00595413Phase 2Results posted
• The Efficacy and Safety of Atacicept in Combination With Mycophenolate Mofetil Used to Treat Lupus NephritisTerminatedNCT00573157Phase 2/3Results posted
• AS900672-Enriched in Ovulation InductionTerminatedNCT00553514Phase 2Results posted
• Investigation of a Long-Acting Follicle Stimulating Hormone in Infertile Women Undergoing Assisted Reproductive Technology (ART)CompletedNCT00505752Phase 2Results posted
• Rebif New Formulation (RNF) Quality of Life (QOL) StudyCompletedNCT00472797Phase 3Results posted
• Cetuximab and Cisplatin in the Treatment of "Triple Negative" (Estrogen Receptor [ER] Negative, Progesterone Receptor [PgR] Negative, and Human Epidermal Growth Factor Receptor 2 [HER2] Negative) Metastatic Breast CancerCompletedNCT00463788Phase 2Results posted
• Saizen® E-Device User TrialCompletedNCT00450190Phase 3Results posted
• A Study to Evaluate Rebif® New Formulation (Interferon-beta-1a) in Relapsing Remitting Multiple SclerosisCompletedNCT00441103Phase 3Results posted
• Study to Evaluate the Efficacy and Safety of FOLFOX-4 Plus Cetuximab Versus UFOX Plus Cetuximab.CompletedNCT00439517Phase 2Results posted
• A Phase 2 Study of Cladribine Add-on to Interferon-beta (IFN-beta) Therapy in Multiple Sclerosis (MS) Subjects With Active Disease (ONWARD)CompletedNCT00436826Phase 2Results posted
• A Phase 2 Dose-finding Study of Atacicept in Subjects With Rheumatoid Arthritis (AUGUST I)CompletedNCT00430495Phase 2Results posted
• RNF and Betaseron® Tolerability StudyCompletedNCT00428584Phase 3Results posted
• Cancer Vaccine Study for Unresectable Stage III Non-small Cell Lung Cancer (START)CompletedNCT00409188Phase 3Results posted
• REbif FLEXible Dosing in Early Multiple Sclerosis (MS)CompletedNCT00404352Phase 3Results posted
• Study To Evaluate The Immunogenicity And Safety Of r-hIFN Beta-1a (Rebif®) Using Clone 484-39 In Multiple SclerosisCompletedNCT00367484Phase 4Results posted
• Rebif® Pregnancy RegistryCompletedNCT00338741Results posted
• Luveris® (Lutropin Alfa for Injection) in Women With Hypogonadotropic Hypogonadism (Luteinizing Hormone [LH] Less Than [<] 1.2 International Unit Per Liter [IU/L])TerminatedNCT00328926Phase 4Results posted
• A Multicentre, Open Label Phase IIIb/IV Study of Subcutaneously Administered Raptiva in the Treatment of Adult Subjects With Moderate to Severe Plaque PsoriasisCompletedNCT00287118Phase 4Results posted

← Merck KGaA, Darmstadt, Germany overview and focus areas